StonvexLoading…
StonvexStonvexStonvexCore line items from AVTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 |
|---|---|---|---|---|
Revenue | $59.00K | $0.00 | $441.00K | $249.00K |
Operating Income | $-72.92M | $-53.18M | $-68.51M | $-55.20M |
Net Income | $-78.26M | $-64.54M | $-35.13M | $210.00K |
EPS (Diluted) | $-5.84 | $-5.47 | $-20.91 | $-22.63 |
Total Assets | $116.46M | $125.10M | $150.73M | $98.45M |
Total Liabilities | $33.41M | $33.55M | $17.70M | $75.72M |
Cash & Equivalents | $15.86M | $26.96M | $134.55M | $81.86M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-49.06M | $-34.01M |
Shares Outstanding | 18.51M | 17.83M | 10.47M | 9.68M |